已阅读5页,还剩12页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Characterization of unresectable cholangiocarcinoma patients treated with or without chemoradiation,Author(s): Jane Elizabeth Rogers Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX J Clin Oncol 33, 2015 (suppl 3; abstr 403) Reporter DR pengying,Background,Curative treatment for CC is surgical resection. Unfortunately, most CC patients (pts) present with unresectable disease in which gemcitabine plus platinum (GEM-P) chemotherapy is the mainstay of treatment (tx). Advanced CC has a dismal prognosis with 5-year survival reported at 5-10 %. Data regarding chemoradiation (CRT) in pts with unresectable CC (uCC) remains limited.,Introduction,Biliary tract cancers,including cholangiocarcinoma (CC) and gallbladder cancers, are rare with limited data ragarding treatment. Most patients present with unresectable CC resulting in a poor prognosis. CRT is the mainstay of treatment for uCC. There is limited data regarding localized therapy with CRT.,Methods,We retrospectively reviewed uCC pts from 1/1/2009 to 7/31/2013. Primary objective: Determine the percentage of pts treated with CRT Evaluate the median number of chemotherapy cycles given prior to CRT,Secondary objectives: Disease response to first-line tx Duration of CRT control Progression-free survival (PFS) with or without CRT overall survival (OS) with or without CRT,Inclusion criteria: uCC diagnosis, received tx, and had follow-up at our institution. Exclusion criteria: pts who received liver-directed therapy other than CRT, mixed histology tumors, and a history of other malignancies.,Results,114 pts were included with 62% having intrahepatic CC. Median age: 63 Gender: females (53.5%); male (46.5%). Site of disease: intra (62%), Hilar (24%), Extra (14%) .,65% of pts received CRT(7% radiation alone) with a median of 6(range 0-26) chemotherapy cycles given prior to CRT. 66% received gemcitabine + platinum (cisplatin/oxaliplain) as ffirst-line treatment.,Disease control (DC) (response + stable disease) with first-line tx was 75% with 71% receiving GEM-P +/- erlotinib first-line.,DC after CRT was 62% with a median duration of radiation control of 6.4 mths. Median PFS and OS for all pts were 13.4 mths and 27.8 mths, respectively.,Median PFS in the CRT group was 14.5 mths versus 11.4 mths in the no CRT group (p = 0.105). Median OS in the CRT cohort was 29.4 mths, while median OS without CRT was 22.4 mths (p = 0.005).,Median OS and PFS after CRT for pts with DC on first-line tx were 32.0 months (95% CI = 24-44 mths) and 15.7 mths (95% CI =13.5-18.8 mths), respectively. Pts who progressed on first-line tx and received CRT had a median OS of 23.8 mths (95% CI = 7-30 months) and median PFS of 4.2 mths (95% CI = 2.3-9 mths).,Conclusions,Our retrospective review reveals a significant improvement in median OS with CRT in uCC pts. Those with DC on first-line tx showed improvement in PFS and OS with CRT. Patient selection is key
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2026年西式烹调师考试题及答案
- 2026年医学影像人工智能诊断考试题库带答案
- 2026年民航初级安检模拟试卷带答案
- 2026年生理考试题库带答案
- 2026年康复医学练习题库及参考答案
- 2026年南京地铁招聘地铁信号巡检工考试题库及答案
- 2026年应用心理学模拟试卷(含答案)
- 2026年职业技能鉴定标准考试模拟试卷(含答案)
- 2026年美容师高级理论考试题库及答案
- 2026年医学急救笔试题库及答案
- 江苏常州市常州花园中学等校2026-2027学年八年级上学期数学期中试卷(含答案)
- 2026年消防设施操作员(初级)实操考核试题及答案
- 儿童情绪调节量表
- 高盛-全球半导体:芯片系列第四篇:中国半导体自给自足建设推进-Global Semis CHIPS IV:China Semis self-sufficiency builds-20260824
- 2026年新教材人教版九年级上册英语Unit 2 Inspiring people 教案
- 学校校务公开及信息发布管理办法
- 预制管桩雨季施工方案
- 人教版川教版 三年级上册《生命生态安全》简述式教案
- 2026年前程无忧性格测试题目及答案
- 2026天津市气象部门事业单位招聘应届毕业生1人(第2号)笔试考试备考试题及答案解析
- 2026 年国家公务员考试申论 20 大热点押题及解答
评论
0/150
提交评论